v1
Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results.
Identifier:nobleid.org/w1/20260515/AEC2C3EB
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/AEC2C3EB)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →